About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3589459
Allelic
Composition
Lmnatm3Stw/Lmnatm3Stw
Genetic
Background
involves: 129S1/Sv * 129S4/SvJaeSor * C57BL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Lmnatm3Stw mutation (0 available); any Lmna mutation (84 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• homozygotes generally die between 12 - 14 weeks of age with none surviving past 16 weeks of age
• in at least 3 homozygotes death resulted from bradyarrhythmia

growth/size/body
• homozygotes display decreased weight gain starting around 4 weeks of age

cardiovascular system
• loss of sarcomere organization is seen in cardiomyocytes and nuclear defects are seen
• degeneration is associated with decreased fiber size, fragmentation, increased granular cytoplasm with loss of striation, and occasional vacuolation
• dilation of the chambers is accompanied by thinning of the chamber walls
• moderate degeneration of cardiac muscle but only very mild degeneration of skeletal muscle is seen
• increased cardiac interstitial fibrosis is seen at 9 weeks of age; however, no increase in apoptosis is detected
• increased levels of atrial natriuretic peptide and B-type natriuretic peptide are seen
• progressive decrease in ventricular fractional shortening is seen starting at 8 weeks of age and left ventricular end-diastolic dimension is significantly larger compared to controls when normalized to body weight
• continuous electrocardiographic monitoring revealed periods of extreme bradycardia and excessive diurnal variation in heart rate in 8 week old mutants
• continuous electrocardiographic monitoring revealed a variety of conduction abnormalities including 2 mice with progressive prolongations of the PR interval

behavior/neurological
• just prior to death homozygotes display reduced activity

muscle
• loss of sarcomere organization is seen in cardiomyocytes and nuclear defects are seen
• degeneration is associated with decreased fiber size, fragmentation, increased granular cytoplasm with loss of striation, and occasional vacuolation
• dilation of the chambers is accompanied by thinning of the chamber walls
• moderate degeneration of cardiac muscle but only very mild degeneration of skeletal muscle is seen
• increased levels of atrial natriuretic peptide and B-type natriuretic peptide are seen
• progressive decrease in ventricular fractional shortening is seen starting at 8 weeks of age and left ventricular end-diastolic dimension is significantly larger compared to controls when normalized to body weight

integument
• just prior to death homozygotes appear slightly disheveled

cellular
• increased cardiac interstitial fibrosis is seen at 9 weeks of age; however, no increase in apoptosis is detected

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
dilated cardiomyopathy 1A DOID:0110425 OMIM:115200
J:100393


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory